Jointly sponsored by the American Academy of CME, Inc and Princeton CME

Types of Credit

CME, CNE, CPE

Target Audience

This activity is designed for managed markets physicians, pharmacists, and nurses.

Learning Objectives

After completing this activity, participants should be able to:

• Define the prevalence and clinical and economic burden of chronic
  constipation and irritable bowel syndrome with constipation (IBS-C)
• Compare and contrast the symptoms of chronic constipation and IBS-C to
  evaluate current diagnostic approaches and opportunities for improvement
• Summarize the benefits and limitations of traditional methods and novel
  treatments for the management of chronic constipation and IBS-C
• Incorporate current evidence into clinical and formulary decisions to
  improve outcomes in patients with chronic constipation and IBS-C

Grant Support

This activity is supported by an educational grant from Sucampo Pharmaceuticals,
Inc and Takeda Pharmaceuticals North America, Inc.